Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial...
-
Salience Lab’s Innovative Architecture leverages Tower’s differentiated Silicon Photonics platforms to deliver ultra-low latency, high-bandwidth and lower-power optical connectivity for AI clusters ...
-
Highlights (unaudited): Consistent Revenue Growth: Immuron is no longer just a "concept" company. Global H1 FY26 sales grew to AUD$4.2 million, with the U.S. market showing strong momentum (+17%...
-
Katapult to release Q4 and 2025 results on March 11, 2026
-
LONDON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Global stability is entering a new phase – one defined not by clear lines of conflict, but by the ambiguous, deniable and strategically choreographed...
-
First equity-linked ETP from 21shares provides exposure to a bitcoin-backed digital yield instrument with a high yield income Zurich, February 25, 2026 – 21Shares AG, one of the world’s leading...
-
ASML publishes 2025 Annual Reports VELDHOVEN, the Netherlands, February 25, 2026 – Today, ASML Holding NV (ASML) has published its 2025 Annual Reports. The 2025 Annual Reports 'Powering technology...
-
加利福尼亚州卡尔弗城, Feb. 25, 2026 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc. (Nasdaq:SNAL,以下简称 “Snail Games” 或“公司”) 宣布,其独立游戏发行分支 Wandering Wizard 将携即将推出的新作《绿石守卫者》(Stoneguard) 与《覆雪之上》(Above The...
-
加州卡爾弗城, Feb. 25, 2026 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商和發行商 Snail, Inc. (Nasdaq: SNAL)(「Snail Games」或「公司」)今日宣佈,旗下獨立遊戲發行部門 Wandering Wizard 於 Steam Next Fest 期間,展出了其備受期待的遊戲新作《Stoneguard》 及 《覆雪之上》...
-
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...